-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Freeline Therapeutics Holdings plc quarterly/annual General and Administrative Expense history and growth rate from Q1 2020 to Q1 2023.
- Freeline Therapeutics Holdings plc General and Administrative Expense for the quarter ending March 31, 2023 was $8.05M, a 2.08% decline year-over-year.
- Freeline Therapeutics Holdings plc annual General and Administrative Expense for 2022 was $30.7M, a 31.2% decline from 2021.
- Freeline Therapeutics Holdings plc annual General and Administrative Expense for 2021 was $44.6M, a 69.5% increase from 2020.
- Freeline Therapeutics Holdings plc annual General and Administrative Expense for 2020 was $26.3M, a 58.4% increase from 2019.
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)